These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 623438)

  • 1. Macrophage electrophoretic mobility and structuredness of cytoplasmic matrix.
    Bagshawe KD
    Antibiot Chemother (1971); 1978; 22():155-60. PubMed ID: 623438
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.
    Cercek L; Cercek B
    Eur J Cancer (1965); 1977 Sep; 13(9):903-15. PubMed ID: 334557
    [No Abstract]   [Full Text] [Related]  

  • 3. Simplified cell microelectrophoretic method applied to the macrophage electrophoretic mobility test for cancer diagnosis.
    Fike RM; van Oss CJ
    Immunol Commun; 1979; 8(2):173-84. PubMed ID: 86499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the macrophage electrophoretic mobility test (MEM) in cancer diagnosis.
    Crozier EH; Hollinger ME; Woodend BE; Robertson JH
    J Clin Pathol; 1976 Jul; 29(7):608-9. PubMed ID: 988059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macrophage electrophoretic mobility test for malignancy.
    Lubran MM
    Ann Clin Lab Sci; 1974; 4(2):121-4. PubMed ID: 4132114
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison between the macrophage electrophoretic mobility (MEM) and the fixed tanned erythrocyte electrophoretic mobility (FTEEM) tests in the detection of cancer.
    Harlos JP; Weiss L
    Int J Cancer; 1978 Apr; 21(4):413-7. PubMed ID: 78907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of osmomolarity, calcium and magnesium ions on the structuredness of cytoplasmic matrix (SCM).
    Cercek L; Cercek B
    Radiat Environ Biophys; 1976 Mar; 13(1):9-12. PubMed ID: 959479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
    Müller M; Irmscher J; Fischer R; Heidl G; Grossmann H
    Cancer Lett; 1977 Jan; 2(3):139-45. PubMed ID: 65215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the structuredness of cytoplasmic matrix (SCM) induced in mixed lymphocyte interactions.
    Cercek L; Cercek B
    Radiat Environ Biophys; 1976 Mar; 13(1):71-4. PubMed ID: 134391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
    Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
    Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte fluorescence polarization measurements with the cellscan system: application to the SCM cancer test.
    Deutsch M; Ron I; Weinreb A; Tirosh R; Chaitchik S
    Cytometry; 1996 Feb; 23(2):159-65. PubMed ID: 8742175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunodiagnosis of malignant tumors. Test of electrophoretic mobility of macrophages].
    Strejcek J; Jíra M; Suhajová E; Písa P; Malbohan I
    Cas Lek Cesk; 1984 Apr; 123(17):511-6. PubMed ID: 6380732
    [No Abstract]   [Full Text] [Related]  

  • 14. The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
    Glaves D; Harlos JP; Weiss L
    Int J Cancer; 1977 Apr; 19(4):474-81. PubMed ID: 66210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer Suppl; 1973 Aug; 1():229-36. PubMed ID: 4804283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macrophage electrophoretic mobility test (MEM) and tanned erythrocyte electrophoretic mobility test (TEEM) for cancer diagnosis (author's transl)].
    Zhao BH; Hu JK; Liang JX
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):195-200. PubMed ID: 553795
    [No Abstract]   [Full Text] [Related]  

  • 17. Technical aspects of the macrophage electrophoretic mobility test in transplantation immunity.
    Malkovský M; Bubeník J; Holán V; Hasek M
    Folia Biol (Praha); 1979; 25(3):179-87. PubMed ID: 385372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease.
    Pritchard JA; Moore JL; Sutherland WH; Joslin CA
    Br J Cancer; 1973 Jan; 27(1):1-9. PubMed ID: 4686176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
    Field EJ; Caspary EA; Smith KS
    Br J Cancer Suppl; 1973 Aug; 1():208-14. PubMed ID: 4140728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage electrophoretic mobility (MEM) test in malignant gynaecological diseases.
    Jenssen HL; Köhler H; Günther J; Klausch B; Straube W; Hofmann R; Büttner HH
    Arch Gynakol; 1976 Mar; 220(3):191-8. PubMed ID: 773334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.